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ABSTRAGTV:-::\- ;

The obese iob/ob) mouse exhibits an inability to

synthesize leptin and thus serves as an excellent model to

study the effects of leptin through its reintroduction.

Leptin is a hormone produced by adipocytes and has been

\

shown to upregulate metabolic expenditure and

thermogenesis, induce lipolysis, and cause appetite
suppression.

It has not been established if leptin is able

to exert its actions directly or by stimulating the release

of thyroid hormone (T3).

In this study, twenty C57BL/6J-ob

iiormal (+/?) and homozygOuS obese iob/bb) mica bestween the
ages of 8-10 weeks were treated for nine days with either
saline vehicle, leptin, iopanoic acid, or leptin plus

iopanoic acid (n=5/group).

Iopanoic acid was used to

prevent leptin from inducing the conversion of T4 into T3.
Daily measurements of body weight, food consumption, oxygen
consumption, carbon dioxide production, and infrared
emission were collected in both +/? and ob/ob treatment

groups.

Iopanoic acid was ineffective at reducing serum T3

in +/? mice, however it successfully reduced T3 synthesis in

ob/ob mice relative to vehicle treated ob/ob mice,
Vehicle treated ob/ob mice displayed a greater food

consumption than vehicle treated +/? mice, while both

leptin and ippanpic acid + leptin treatment effectively

reduced appetite in oJb/ojb mice below oJb/ob vehicle
treatment groups.

With respect to vehicle treated ob/ob

mice, a lower day 10 body weight was observed ah both

leptin and iOpanoic acid + leptin treated bb/^ob mice, while
the mean body weights for iopanoic acid treated ob/ob mice
remained unchanged.

Iopanoic acid was effective at

depressing serum T3 in ob/ob mice which also showed a
reduction in body weight similar to that of leptin treated
ob/ob mice, thus the effect of leptin on weight reduction
cannot be attributed to mediation by T3.

.

Vehicle treated ob/ob mice displayed a lower day 10

radiant body heat with respect to vehicle treated +/? mice
(31.5 + 0.3 °C

vs. 33.9 + 0.4 °C, respectively).

Iopanoic

acid treated ob/ob mice displayed radiant body heat
emission similar to those of vehicle treated ob/ob mice.

However, both leptin and iopanoic acid + leptin treated
ob/ob mice showed higher radiant body heat than both

vehicle and iopanoic acid ob/ob treatment groups.

This

suggests that the thermogenic effects of leptin are

similar in both leptin and iopanoic acid + leptin ob/ob
treatment groups.

Iopanoic acid was ineffective at

reducing serum T3 in +/? Mice, however it successfully

reduced T3 synthesis in oJb/oJb mice relative to vehicle
treated ob/ob mice.

Thus the reduction of serum T3 ih the

iopanoic acid + leptin treatment group shows that this
thermogenic influence of leptin occurs without increasing T3
concentrations.

Vehicle treated ob/ob mice had the highest serum T3
concentrations relative to all other treatment groups, and

they also displayed total oxygen consumption rates similar

to vehicle treated +/? mice (3.8 + 0.8 ml O2 ' min'^ vs. 3.9
+ 0.6 ml O2 * min"^, respectively).

The reduction of T3 in

iopanoic acid treated ob/ob mice caused a decline in oxygen

consumption, relative to vehicle treated ob/ob mice (2.6 +

0.8 ml O2' min'^ vs. 3.9 + 0.6 ml O2' min"^, respectively).
An elevated metabolic rate in both leptin and iopanoic acid

+ leptin ob/ob mice relative to iopanoic acid treated ob/pb
mice suggests that leptin is acting through T3 to induce

metabolism.

Leptin deficient iopanoic acid treated ob/ob

mice display low serum T3 relative to vehicle treated ob/ob
mice, and consequently have low metabolic rates relative to
the same control group.

Administration of leptin to

iopanoic acid + leptin ob/ob mice resulted in a similarly
elevated metabolic rate without an increasing serum T3.

This confirms that metabolic expenditure can be induced by

leptin and without indirectly increasing serum T3
concentrations.
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CHAPTER ONE: INTRODUCTION

Thermogenesis from Oxidative Metabolism

The development of obesity is a major complication

associated with the pathology of Non Insulin Dependent
Diabetes Mellitus (NIDDM).

Increased body weight is

inversely proportional to insulin sensitivity and thus
contributes to a decreased ability to transport glucose

into the cells resulting in hyperglycemia.

Weight loss

improves both insulin sensitivity and glycemic control in j
obese individuals suffering from NIDDM.

Thus researchers

are looking at mechanisms of inducing metabolic expenditure

in order to mobilize stored fat reserves and to ultimately
reduce body weight and lead to an improvement of the
diabetic state.

The production of heat resulting from overall energy
expenditure is categorized by Himms-Hagen (1989) as either
obligatoiry or facultative thermogenesis.

The amount of

heat produced through obligatory thermogenesis is

relatively low and results from thermic effects of food
ingestion and energy expended during growth, pregnancy, and
lactation.

Facultative thermogenesis results from

metabolic processes which can be rapidly regulated and
includes exercise-stimulated thermogenesis, involuntary

skeletal muscle shivering, and nonshivering thermogenesis.
The overall metabolism of all tissues is responsible for

maintaining obligatory thermogenesis while facultative
thermogenesis is primarily observed in skeletal muscle and

brown adipose tissue.

Targeting facultative thermogenic

tissue to increase energy expenditure has recently become a
candidate for the treatment of obesity.

The specific metabolic events contributing to
facultative thermogenesis occur as a by-product of

oxidative metabolism.

A comparison of the change in

enthalpy for cellular substrate oxidation to that of ATP

hydrolysis shows that the cellular production of heat

mainly occurs in the process of ATP production as opposed
to ATP usage (Prusiner and Poe, 1968).

The donation of

electrons to the mitOGhondrial electron transport system

through the oxidation of reduced nucleotides produces a

electrochemical gradient which is then dissipated through
the inner membrane bound Fi/Fo/ATP syhthase and results in
the phosphorylation of ADP.

Much research has focused

attention on the mechahism and regulation of uncoupling

metabolic oxidation from the phosphdrylation of ADP.
In order to uncouple oxidative phosphorylation the
mitochondrial

electrocheinical gradient is dissipated

through an inner membrane protein called uncoupling protein
(UCP) (Klingenberg et. Al., 1985).

As a result of

mitochondrial uncoupling, substrate utilization and oxygen
consumption are maintained or can be potentially

upregulated while ATP synthesis is no longer tightly
coupled to the oxidation of substrates.

Scientists have

directed their attention towards this inner mitochondrial

membrane bound uncoupling protein as a candidate for

inducing metabolic expenditure and thus ultimately reducing
body weight.

The normal role of this protein is to

dissipate the hydrogen ion electrochemical gradient
established through oxidative metabolism and ultimately
result in heat production for the maintenance of body

temperature in hoiheothermic animals (the detailed mechanism
will be discussed in the next section).

Clinical induction

of uncoupling protein (UCP) will permit increased metabolic

expenditure while not increasing ATP synthesis, and heat
will be produced as a metabolic by-product thus allowing

adipose reserves to be increasingly mobilized thus serving
as a substrate for this thermogenic process.
Thermogenic Tissues

Facultative thermogenesis is divided into heat

produced through muscular activity and excercise.

shivering, and non-shivering thermogenesis (Schmidt-Nelson,
1990).

Shivering thermogenesis results from acute

involuntary skeletal muscle contraction and aids in

maintaining body temperature during drastic environmental

temperature changes.

Non-shivering thermogenesis was

initially described to function in the thermal balance of
mammals undergoing cold acclimation, in small mammals

arising from hibernation, and in newly born mammals.

Brown

adipose tissue was initially established as the organ

responsible for the mechanism underlying this thermal
balance (Himms-Hagen, 1990).

The role of brown adipose tissue as a contributor .to
whole body thermogenesis is related to its structural

composition.

Brown adipose tissue consists of

approximately 40% brown adipocytes with the remaining mast
cells, interstitial cells and preadipocytes that

differentiate into brown adipocytes.

The characteristic

brown color of BAT is the result of high densities of

mitochondria with iron containing cytochromes.

The rich

vasculature of BAT permits the flow of blood from this
tissue to be rapidly dispersed to tissues and organs of the
body (Himms-Hagen, 1990).

The contribution of BAT to nonshivering thermogenesis

in newborn mammals was partly established through studies

performed by Heim and Hull (1968) which demonstrated that
BAT in newborn rabbits accounts for at least 70% of the

increased oxygen consumption following norepinephrine
infusion.

Himms-Hagen (1?89) found a tight correlation

between the species-specific thermal requirement and brown
fat development.

For example, mamma.ls born well developed

and able to live independently very early in life, such as

the dog and guinea pig, have BAT which is fully developed
at birth and atrophies shortly therea-fter.

However mammals

such as the Syrian hamster, which is born poikilothermic,
initiates BAT development at approximately 2 weeks of age,

when it is able to maintain a constant body temperature.

After it was established that BAT is a major contributor to
thermoregulation, researchers began proposing

it as a

potential target to induce metabolic expenditure (Himms-

HageUj 1989). Unfortunatelyj adult human's lack sufficient
quantities of BAT to influence total body temperature and
thus specific inductive targeting of BAT could hot
sufficiently mobilize stored fat reserves and cause a
decrease in body weight.

Brown adipose tissue is not the

only tissue responsible for maintaining heat balance

through non-shivering thermogenesis,

Recent research has

demonstrated that the uncoupling mechanism responsible for

heat production in brown adipose tissue is also found
within other thermogenic tissues of the body, namely
skeletal muscle (Ross et al., 1997).

When the mechanism of thermogenic uncoupling was
discovered to be homologous in skeletal muscle to that of

brown adipose tissue researchers began looking at muscle as

a target for metabblic induction in humans suffering from

obesity.

Skeletal muscle constitutes 42% of body mass in

both humans and rats and, due to its high mass, greatly

contributes towards whole body oxygen consumption relative
to other tissue types.

Therefore many investigators

support it as a primary tissue for clinically targeting the
induction of metabolic uncoupling and the treatment of
obesity.

History of Uncoupling Protein

During the early to mid 1970's research focussed on

the influence of fatty acids on the induction of oxidative

uncoupling and nucleotides inducing recoupling in BAT
mitochondria (Cannon et al., 1973; Rafael et al., 1969;

Hittelman et al., 1969).

Heaton et al. (1978) identified a

32,000-Mr protein responsible for proton conductcuice.

However it remained uns«^ttled as to

this newly

discovered protein was resppnsible for the

lionshivering

thermdgenesis attributed to torOwri fat1 Support fob this
came from an pbserved correlation betWeen the thermogenic

output and the newly discovered 32,00G-Mr protein in animals
which vary in thermogenic capacity {Nicholls and Locke,
1984).

For instance, the decline in npnshivering

thermogehesis during guihea^^^^^^

correlates with

the decline in both the amount of the 32,000-Mr protein, and

the proton conductance of the inner mitochondrial membrane
(Nicholls and Locke, 1984).

This particular uncoupling

protein was isolated by Lin and Klingenberg (1982) and
found to be solely expressed in brown adipose tissue (BAT).
Several observations led to the hypothesis that

mitochondrial uncoupling of oxidative phosphorylation
exists in tissues other than BAT.

It was observed that the

inner mitochondrial membranes of isolated intact liver

cells were permeable to protons and that cellular oxygen

consumption, for the purpose of maintaining the
electrochemical gradient against the proton leak, accounted

for approximately 26% of the total resting respiration rate
in isolated liver cells and approximately 52% of resting
rat skeletal muscle (Brand et al., 1994; Rolfe and Brand,

1996),

These studies confirmed that the proton leak in rat

liver, skeletal muscle and heart contribute to an average
20% of the standard metabolic rate in the adult rat (Nobes

et al., 1990; Brown et al., 1990; Brand et al., 1994; Rolfe

& Brand, 1996)

The proton leak in these tissues, as well

as in brain and kidney, suggested the presence of a

mechanism of uncoupling in tissues other than that

previously described in BAT (Rolfe et al., 1994).

Further

evidence supporting the need for a mechanism to regulate

energy expenditure in tissues other than BAT was that adult
humans have very little BAT (Cunningham et al., 1985;
Garruti et al., 1993; Lean et al., 1986).

Furthermore,

although obese mice demonstrate atrophied BAT and low
thermogenic output, mice where UCP is not expressed in BAT
are not always obese.

This compounding evidence led to

studies in which several other UCP's, with high homology to

the UCP expressed in BAT (now defined as UCPl), were
identified and characterized (tablel):

UCP2 (Fleury et

al., 1997; Gimeno et al., 1997; Boss et al., 1997), UCP3
(Boss et al., 1997; Solanes et al., 1997), and UCP4 (Mao et
al., 1999).

Table 1. Uncoupling proteins and the tissue types
where they have been isolated.

BAT=brown adipose

tissue, WAT=white adipose tissue, SM=skeletal
muscle

Uncoupling Protein Type

Tissue

UCP2

BAT, WAT, SM, Heart

Kidney, Lung, Placenta
Lymphocytes
UCP3

BAT, SM

UCP4

Brain

Characteristics of Uncoupling Protein

All UCP's belong to the gene family of mitochondrial
anion carrier proteins which include the ATP/ADP
translocator, the phosphate carrier, the

2-oxygluturate /malate carrier, and the citrate carrier
(Palmier, 1994).

All members of this family have three

highly conserved repeated domains.

Two transmembrane

domains exist within each repeating unit and a highly
conserved basic motif, containing the amino acid residues

allbnb (a=acidic, l=lipophilic, b=basic, n=neutral), occurs

after the first transmembrane domain of each repeat

(Klingennberg, 1993).

Human UCPl and UCP2 are 59%

identical at the amino acid level, and UGP3 is 57% and 71%

identical to UCPl and UCP2, respectively (Vidal-Puig et
al., 1997).

UCP3 exists in a both short and a long forms

(Boss et al., 1997; Solanes et al., 1997);

the short form

of UCP3 is missing 37 amino acids at the C-terminus that

are present in the long form and which are also found in
UCPl and UCP2.

There is no change in the ratio of long to

short form of the transcript in obese and lean subjects
before and after caloric restriction (hypocaloric diet of
1045kJ/day for 5 days) suggesting the absence of alteration

of gene regulation and alternative splicing in the skeletal
muscle of obese subjects (Millet et al., 1998).

Separate

studies by Boss et al. (1997) and Solanes et al. (1997)

suggest the C-terminus present in the long form, but not in
the short form, contains a transmembrane domain that may
function to correctly insert UCP into the membrane.

The mechanism by which uncoupling protein facilitates
the dissipation of the H"^ gradient across the inner
mitochondria! membrane has been described to be driven via

fatty acid cycling (Garlid et al., 1996; Jezek et al.,
1998).

The proposed mechanism of fatty acid cycling works

^ ■
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through a membrane bound domain of the UCP that contains ah

anion conductance pathway.

The transportating of

begins

with protination of a membrane bound fatty acid which then

flips to the iriatrix and delivers a H"^ down its gradient via
nonionic diffusion.

The bilayer energy barrier is too high

to allow the flux of tha Fatty acid (FA) anion back across

the membrane.

The energy barrier is reduced by the anion

conductance pathway of the UCP.

The FA anion flip-flops to

the other side of the membrane, along the provided
conductance pathway, and becomes protinated for a nonionic

diffusion to complete the cycle.

UCP2 and UCP3 are

suggested tp both facilitate the transport of

through the

same mechanism of fatty acid Cycling (Jezek et al., 1998).
Leptin as a Satiety Factor and Regulatbr of Metabolic
Expenditure

The ob gene encodes a 167 amino acid peptide called
leptin which is expressed in brown a.nd white adipose
tissue, placental tissue, and regions along the
gastJ^ointestinal tract (Prolo et al., 1998; Auwefx and

StaelS/ 1998).

Leptin reduces appetite and induces

metabolic expenditure by regulating the level of central
nervous system activity, specifically the expression of

hypothalamic neuropeptide y (NPY).

■ 11'

■

The NPY is a stimulator

of feeding and inhibitor of brown fat uncoupling^^^^^p^^

thermogehesis activity (kotz et al.,■ i598)v.

Leptih has

been shown to inhibit NPY release frort the h^othalam
arcuate nucleus and subsequently results in decreased

f eeding and an increased BAT UCPl expressioh (Kotz et a.1.,

::T998i

V

.'C. •

Leptin's action on peripheral cell activity is the
result of both direct leptin

receptor binding and

activation of the sympathetic nervous system.
Catecholamine levels have been shown to rise in a dose

dependent manner with leptin administration.

Adipocyte

beta-adrenergic receptor binding of catecholamines



activates intracellular adenylate cyclase and, through a
signal transduction cascade, activates triglyceride lipase

catalyzing the breakdown of triacylglycerol.

While

sympathetic nerve activity increases adipocyte lipolytic
activity, simultaneous adiopocyte leptin gene expression is
inhibited. (Hua et al., 1997) .

Leptin acts similarly in

other peripheral tissues to cause the depletion of cellular
triglycerides.

Shimabukuro et al. (1997) demonstrated that

leptin administration causes skeletal muscle, liver, and
pancreas cells to break down intracellular triglycerides.
Furthermore, simultaneous upregulation of free fatty acid

(FFA) oxidation with leptin infusion was suggested by the
absence of an increase in serum FFA content, that should

have resulted from the increased cellular lipolysis.

Leptin induced depletion of FFA content is supported
through a simultaneous upregulation of S-oxidation
(Shimabukure et al., 1997).

An interesting study performed

by Wang et al. (1999) demonstrates through adipocyte cell
culture that leptin and norepinephrine independently induce

lipolytic activity.

Interestingly, norepinephrine

induction of lipolysis results in free fatty acid and

glycerol release, while leptin lipolytic induction was
followed by only glycerol release thus supporting a leptin

induced S-oxidation.

While leptin is inducing fat

oxidation, a simultaneous inhibition of acetyl-CoA

carboxylase activity, the rate-limiting enzyme of fatty

acid synthesis, by leptin subsequently leads to a reduction
of malonyl-CoA (Bai et al., 1996).

Since malonyl-CoA

directly inhibits carnitylacyltransfeirase I, an enzyme
catalyzing the translocation of fatty acid into the
mitochondrial matrix, oxidation will ultimately increase.

Leptin has also been demonstrated to alter peripheral
tissue metabolic expenditure through changes in the

magnitude of oxidative uncoupling.

^3 :

Leptin's action as a

regulator of metabolic expenditure on peripheral tissue
seems to be partly mediated through sympathetic nervous

activity.

Haynes et al. (1997) showed that leptin

increased sympathetic nerve activity to brown adipose
tissue, renal tissue, and the hindlimb.

This upregulation

of catecholamine production induces lipolytic activity thus
resulting in increased serum fatty acid levels (Wang et
al., 1999).

Hwang and Lane (1999) showed that

administration of fatty acids to skeletal muscle cells in
vitro results in a time and concentration dependent

increased UCP3 mRNA expression.

Intralipid infusion mimics

the rise in plasma free fatty acid levels that occurs as a

result of adipocyte fatty acid mobilization during a fasted
state.

Weigle et al. (1998) elevated serum free fatty acid

levels in fed animals through intralipid infusion

(20%

Intralipid) and observed an increased skeletal muscle UCP3
mRNA.

In the same study, fasting rats were observed to

increase serum FFA levels 3-fold, accompanied by increased
skeletal muscle expression of UCP3 and UCP2 mRNA.

The synthesis of catecholamines occur in the CNS,

sympathetic postganglionic neurons, and adrenal chromaffin
tissue.

While both intravenous and intracerebroventricular

injection (ICV) of leptin results in increased plasma

14

catecholamiiie (norepinephrine and epinephrine), ICV

injection requires approximately 100 fold less leptin to
increase catecholamine secretion (Satoli et al,, 1999).

Other ICV leptin injection studies support the idea that
fats were mobilized to fuel an increased uncoupling through

an observed reduction in the respiratory quotient, shifting

from carbohydrate to fat metabolism (Ghibaudi et al.,
1996).

During the ICV leptin injection study performed by

Satoh et al. (1999), both norepinephrine and epinephrine

plasma levels remained elevated and without change for 3
hours post injection.

It is also shown that

a continuous

leptin ICV infusion of 4 days (12 /xl/day) is able to
maintain high levels of UCPl, UCP2, and UCP3 mRNA.

Leptin's Action Through Thyroid Hormone

Thyroid hormone is synthesized in the thyroid gland
through the coupling of iodinated tyrosines to yield both

thyroxine (3,4,3S5'-Tetraiodothyronine, T4) and, to a
lesser amount, triiodpthyronine (3,5,3'-Triiodothyronine,

Ts)!

Both T4 and T3 are secreted into the circulation and

while T3 is the physiologically active form, T4 must be
converted to T3 in order to elict most responses.

The

conversion of T4 to T3 is catalyzed in the peripheral

tissues by either type I or type II T4 5'-monodeiodinase
■ ' ■ 15

(5'-D).

Type I 5'-D is responsible for most of the

conversion of T4 and is found in the kidneys and liver,
whereas type II is found in BAT, brain, and pituitary
gland.,;

T3 stimulates mitochondrial metabolism and oxygen
consumption and thus increases the level of cellular ATP.
T3 also increases the expression of plasma membrane bound

Na'^/K'^-ATPase expression.

Thus both increased levels of ATP

along with T3 stimulated Na^/K^-ATPase expression provides

the basis for the sodium pump theory of thermpgenesis,
which describes the process of ATP hydrolysis by the Na^
pump as an exothermic reaction yielding the production,of

heat for the maintenance of body temperature.

Thyroid

hormone (T3) has also been shown to elicit a thermogenic

effect through increased mitochondrial proton leak in
isolated liver cells (Rolfe and Brand, 1997).

T3 induced expression of

Furthermore

UCPl, UCP2, and UCP3 mRNA is

suggested to contribute to thermogenesis (Boss et al.,
1997; Gong et al,, (1997).

Fehn et al. (2000) reported a similar degree of

metabolic stimulation by both leptin and T3 in the ob/ob
mouse.

However/ the thermogenic and metabolic actions of

leptin through T3 have never been described.
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Our laboratory

has demonstrated, through hrstological analysis of thyroid

glands in obese (ob/qb) mice, an enhanced follicular cell

activity and enlarged Colloids with leptin treatment,
suggesting increased thyroid hormone in response to leptin
(Fehn et

1999).

in addition serum it has demonstrated

increased serum leptin levels in response to T3 treatment.

Thus since both leptin and T3 independently induce
thermpgenic uncoupling and T3 synthesis seems to be

dependent upon serum leptin levels, it is possible to

predict that the thermogenic effect of leptin is through
the induction of T3 synthesis.
Skeletal Muscle Metabolic Uncoupling

Brown adipose tissue (BAT) is well documented to be a

major site of nonshivering thermogenesis in rodents however
its control is defective in most animal models of obesity.

Himms-Hagen (1990) reports that BAT of obese rodents is
thermogenically inactive and exhibits a characteristically

depressed ability to synthesize uncoupling protein, thus
the requirement to thermoregulate in obese animals implies

the existence of uncoupling protein in other tissues.
Furthermore, the presence of relatively small amounts of
BAT in humans supports the need for a mechanism of
nonshivering thermogenesis in tissues other than BAT.

The

discovery of UCP3, expressed primarily in skeletal muscle,
led Inyestigatdrs to target it as ^ potential medns of
clinically regulating metabolic expenditures to tredt

obesity.

Interestingly, both leptin and T3 similarly induce

the genetic expression of skeletal muscle UCP3 (Liu et al.,
1998; Gong et al., 1997).

H-uman skeletal muscle lipolysis is induced through S2

adrenoceptor agonist and not Si- or S3- specific agonists
(Hagstrom-Toft et al., 1998).

It has not been clearly

established if T3 permissively induces the expression or

actiyity of skeletal muscle S2-adrenergic receptor in order
to permit a catecholamine stimulated skeletal muscle
thermogenic response.

.

Neither has it been established if

leptin is able to directly alter skeletal muscle uncoupling
in the absence of centrally mediated adrenergic influence.
Thus it would be of interest to experimentally prevent the

up-regulation of thyroid hormone by leptin and thereby
remove the permissive action of T3 on peripheral tissue
adrenergic receptors.

This would allow investigators to

evaluate leptin's action on peripheral tissue activity

through adrenergic activity and, in the absence of thyroid
hormone's additional influence, would also yield a better
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understanding of the direct action of leptin on peripheral
tissue uncoupling.
Experimental Design

The C57BL/6J obese (ob/ob) mouse exhibits an inability

to synthesize functional leptin and is reported to display
hypothyroidism (low T3, high T4) from 3 to 6 weeks of age
(Oh and Kaplan, 1994).

These mice also exibit a reduced

oxygen consumption and low body temperature (Kaplan and

Leveille, 1974).

Daily injection of ob/ob mice with leptin

reduces body weight and food intake, while increasing

metabolic rate (Pelleymounter et al., 1995).

Studies from

our laboratory have shown that with leptin administration

the ob/ob mouse increases oxygen consximption rates and
thermogenesis (Fehn, et al., 1999).

The mechanism of

leptin stimulation in peripheral tissue metabolic and
thermogenic activity in the absence of T3 has not been
determined and is the focus of this particular research.
As discussed earlier, T3 is synthesized through the

deiodination of T4 by T45'-monodeiodinase.

In order to

evaluate the ability of leptin to stimulate metabolism and

thermogenesis we needed to block leptin's ability to
stimulate T3 synthesis.

lopanoic acid was used to block

renal and hepatic T45'-monodeiodinase.
19

Obese ob/ob and

normal +/? mice were used to measure oxygen consumption,
carbon dioxide production, radiant body heat, and food

consumption while given either saline vehicle, leptin,

iopanoic acid, or leptin in addition to iopanoic acid.
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CHAPTER TWO: MATERIALS AND METHODS

Animals

Twenty of the C57BL/6J-oJb normal (+/?) and homozygous
obese {ob/ob) female mice were ordered from Jackson
Laboratories (Bar Harbor, Maine).

arrive at 8-10 weeks of age r^

three days after arrival.

All mice were ordered to

initial treatment

Mice were housed at five animals

per cage of the same genotype and treatment group and
maintained at approximately 23 °C under a 14:10 light:dark

cycle.

Water and Teklab 4% rodent chow were available ad

libitum.

Experimental Design

Recombinant mouse leptin was purchased from R&D

Systems (#498-OB).

The leptin formulation was lyophilized

from a filtered solution in phosphate buffered saline

(PBS).

Leptin was reconstituted by adding 15mM sterile HCl

(2.5 ml/Smg leptin) to a vial and allowing the protein to
dissolve.

Once leptin was completely dissolved, 7.5 mM of

sterile NaOH (1.5 ml/5mg vial) was added to bring the pH to

approximately 5.2.

The resulting suspension was aliquoted

into microcentrifuge txibes and stored at -20 °C until used,
lopanoic acid was purchased from SIGMA Biochemicals
(Product Number I 2013) and was prepared immediately before

each use by adding 6.25 ml of O.IM NaOH to 125 mg of the

drug.

Once the drug was dissolved, it was titrated with

0.IM HCl to approximately pH 7.8 and then diluted with
distilled water to a volume of 12.5 ml and protected from

Mice were organized into 4 groups with 5 animals per

group.

Each group received daily intraperitoneal

injections of one of the following; leptin (3 |ig/g body
weight; 2.4 /xl/g body weight), iopanoic acid (50.0 /xg/g
body weight; 5.0 /il/g body weight), or both leptin and
iopanoic acid as a double injection (as described above).
Control animals received intraperitoneal injections of _

leptin vehicle (PBS pH 5.2; 2.4 jil/g body weight).
Injections were administered between the hours of 0800
hours and 1200 on nine consecutive days (day 1 through day
9) following readings of O2 consumption, CO2 production,

radiant body heat, and body weight determinations.
Percent change in body weights with respect to day 1
were determined for each animal and statistical analysis
(ANOVA) was performed on last day percent change.

In order

to statistically evaluate all values of percent change as

positive numbers, a constant of 0.25 was added to the
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percent change of each animal and then arcsin

transformation was applied to th^ yalues^^^^ ^
Metabolic Rate Determination

Oxygen consumption and carbon dioxide production were
measured using open flow respirometry with an Ametek S
3A/II O2 analyzer and an Ametek CD-3A CO2 analyzer,
respectively.

Room air was utilized as a reference gas and

assumed to contain 20.96% O2 and 0.03% CO2.

Readings were

taken at a constant flow rate of 400 ml per minute.

Mice

were placed in an open flow container and the fractional
gas content was recorded at the end of 2 minutes, a time
which was determined to provide stable readings.
were weighed after metabolic

determination.

Animals

Results are

reported as total oxygen consumption (ml O2 • min'^).
Respiratory quotients (RQ, ml COa/ml O2) were determined
from oxygen consumption and carbon dioxide production in
order to evaluate metabolic substrate usage
Food Consumption

Daily food consumption was determined for each

treatment group by weighing any uneaten food in both the

tray and inside mouse cage (moisture accumulation was not
detected in uneaten food).

Food was weighed under the

assuniplrion. that moisture frbm saliva and urnine negligably

altered weight.

Food consumption measurements were begun

the same day of treatments and thus pretreatment data are

not available.

Mean daily food consumption (grams/day) was

measured for each group of five mice on each day of the

study.

Data was analyzed for the last three days (days 8

10).

Radiant Body heat Determination

Radiant body heat was deteimined daily using a
thermocouple thermometer (Dual J-T-E-K, model 91100-40)
with an infrared probe (Cole Farmer, model 39652-10 K).

The probe was positioned approximately 2 cm from the
ventral surface of the animal's lower abdomen and held.

until a constant value was obtained (approximately 15

seconds).

Radiant body heat was recorded in °C and used as

an indicator of thermogenesis.
Blood Collection and Serum Thyroid Hormone Determination

Blood was collected via cardiac puncture, and then

sacraficed by CO2 euthanasia. Blood samples were transferred
to 1.5 ml microcentrifuge tubes and placed on ice until
clotted.

Serum was separated from the clot by

centrifugation (15,000 xg) and stored at -20 °C until
assayed.

All samples were subjected to radoimmunoassay

quantification of T3 and T4 using the
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T3 Solid Phase

Component System and the

T4 Mab Solid Phase Component

System (ICN Pharmaceuticals, T3 06B-254215; T4 O6B-254011).

Standards for the T3 kit ranged from 0 ng/dL to 800 ng/dL LTriiodothyronine in human serum with sodium azide.

Standards for the T4 kit ranged from 0 fig/dL to 20 fig/dli Lthyroxine in hviman servim with sodium azide.
Statistical Analyses

All day 10 results were subjected to multifactorial

analysis of variance (ANOVA) and Duncan's Multiple Range
Test (Mason et al., 1989).

Statistical significance is

shown in a chart below each figure or table where treatment

groups intersect (S = significance; NS = not significant).
Missing data points occurred in the following thyroid
hormone groups: vehicle treated +/? T3, and iopanoic acid

treated ob/ob T3.

Subsequently, these same groups had

missing data for the T3/T4 determinations.

After

calculating the ratio (T3/T4) for vehicle treated ob/ob
mice, there was an outlier that was also removed as a

missing data point.

Missing data points were estimated by

the method of Zar, (1984).
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A'+S-a.

For each group where missing data occurred, ANOVA was
calculated as n=4.

All other ANOVA calculations were

reported using n=5 (mean + SD).
declared significant.
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P values

0.05 are

RESULTS

Serum Thyroid Hormones

Serum thyroid hormone (T3) concentrations in vehicle

treated 8-10 week old ob/ob mice were greater than in the
normal vehicle treated group (table 2).

Obese mice treated

with leptin, iopanoic acid, and iopanoic acid + leptin
displayed a lower serum T3 concentrations relative to
vehicle treated ob/ob mice and were not different from
nomal treatment groups.

Iopanoic acid + leptin treated

ob/ob mice displayed a higher ser\im T4 than leptin treated
+/? mice.

The ratio of T3/T4 was also evaluated as an

indication of the T4 converted to T3 through the action,of
T4 5'-monodeiodinase.

No difference

was observed in the

T3/T4 ratio for any of the treatment groups.
Daily Food Consumption

Daily food consumption was measured to confirm
leptin's role as a satiety factor and these data are shown

in figure 1.

Vehicle treated ob/ob mice have a higher food

consumption than +/? vehicle treated mice.

Leptin

treatment resulted in a depressed food consumption in ob/ob
mice relative to vehicle treated ob/ob mice.

Food

consumption by iopanoic acid treated ob/ob mice remained
unchanged with respect to vehicle treated ob/ob mice,
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however it was greater than leptin treated ob/ob mice.

lopanpiG! acid + leptin treated ob/ob mice displayed a
similar food consumption to that df leptin treat

ob/ob

mice, and it was significantly lower than both vehicle and

iopanoic acid treated ob/ob mice.
Body Weight Analysis

Bay 10 body weights for normal (+/?) and obese {fCb/ob)
mice are shown in Figure 2.

All normal (+/?) treatment

groxips display equivalent body weights while vehicle

■

treated ob/ob mice had higher body weights than vehicle

treated +/? miee•

Leptin treatment in ph/oh mice resulted

in lower body weights with respsot to vehicle treated ob/ob
mice.

Obese mice treated with ioparioiC acid had body

weights equal to vehicle treated ob/ob mice.
Administration of iopainoic acid with leptin to ob/ob mice
caused the lowest body weights with respect to all ob/ob
^ treatment groups.

■

Percent change in body weight relative to day 1 is
used to show the relative changes in body weights for each

treatment group (figure 3 a and b).

Statistical analysis

was performed on day 10 percent changes by using arcsin
transformation.

Percent change in body weights for

vehicle, leptin, iopanoic acid, and iopanoic acid + leptin

treated normal (+/?) mice displayed a similar slight

decrease, while iopanoic acid + leptin decreased more than
all other treatment groups by day 10 (figure 3a).

Relative

to vehicle treated ob/ob mice, all ob/ob treatment groups

displayed a lower absolute body weight.

Iopanoic acid

treated ob/ob mice show a smaller percent change in body

weight relative to ob/ob vehicle, while leptin and iopanoic
acid + leptin display lower body weights .

Vehicle and

iopanoic acid treated ob/ob mice gained weight over the
/

course of the study, while leptin and iopanoic acid +

leptin treated ob/ob mice lost weight.
Thermogenic Response

Figure 4 shows that, on day 10, vehicle treated normal
+/? mice have a higher radiant body heat than vehicle

treated obese ob/ob mice.

Leptin treated ob/ob mice have a

higher mean radiant body heat than vehicle treated ob/ob
mice, however the difference was not significant.

Iopanoic

acid treatment did not result in a change in radiant body

heat in ob/ob mice relative to vehicle treated ob/ob mice,
however the administration of iopanoic acid with leptin

resulted in a higher thermogenic response relative to
vehicle treated ob/ob mice.
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Oxygen Consumption Analysis

Oxygen consumption rate (ml O2 " min
an indicator of metabolic expenditure.

was measured as
All day 10 normal

(+/?) treatment groups displayed no difference in total

oxygen consumption rat^ (figure 5). Leptin treatment in
ob/ob mice did not change oxygen consumption rate relative
to vehicle treated Ojb/oJb mice while iopanoic acid treated

ob/oJb mice had lower oxygen consumption rates relative to
both vehicle and leptin treated ob/ob mice,

Leptin

treatment coupled with iopanoic acid prevented the decrease

in oxygen consumption rate relative to iopanoic acid
treatment alone.

.

Respiratory Quotient

Respiratory quotients (RQ) were used to assess which
substrate (fat, carbohydrate, or protein) was primarily

metabolized by mice in each treatment group (figure 6).

Day 10 vehicle treated normal mice had RQ values below that
which would be calculated for pure fat metabolism.

All

other normal and obese day 10 treatment groups had RQ

values that suggested fat metabolism.
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CHAPTER FOUR; DISCUSSION

Previous research has shown that food restricted obese

ob/ob mice display depressed levels of T3 and T4 relative to
normal mice (Oh and Kaplan, 1994).

Results of the current

study contrast with Oh and Kaplan (1994) in that obese
(ob/ob) mice display significantly higher levels of serum T3
than vehicle treated normal (+/?) mice, whereas T4 levels in

+/? and ob/ob mice are equal.

However, food restriction

has been shown to reduce plasma T3 levels (Cokelaere et al.,

1996; Oberkotter and Rasmussen, 1992), and since the mice
used in this study had free access to food, the differences

in serum thyroid levels observed between studies may
reflect the effects of food restriction.

Leptin has been shown to induce metabolic expenditure

(Pelleymounter et al., 1995) and previous research in the
host laboratory suggests that its action on peripheral

tissues may potentially be regulated through the induction

of thyroid hormone (Fehn et al., 1999). The obese ob/ob
mouse lacks functional leptin and was initially suspected

to display reduced serum

T3 levels with respect to normal

mice, thus making it an excellent model to study the

effects of leptin replacement on T3 production.

lopanoic

acid was used to inhibit T4 5'- monodeiodinase and thus
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prevent leptin's proposed ability to increase the

production of T3.

All normal (+/?) mice displayed equal

quantities of serum T3 regardless of treatment, in spite of
the fact that +/IOP treated mice were predicted to display

significantly depressed T3 concentrations.

Interestingly,

iopanoic acid was effective at reducing serum T3 levels in
ob/ob mice relative to vehicle treated ob/ob mice.

The

form of iopanoic acid used in this study was different than

previously used in our laboratory and thus the pH stability
and effective dosages may have been different.

Ideally a

preliminary iopanoic ^cid dose response analysis should
have been performed.

In the current study leptin treated ob/ob mice
displayed a lower serum T3 concentrations as compared to
vehicle treated ob/ob controls (table 2).

These results

and those reported by Fehn et al. (1999) Suggest that while

the thyroid gland activity is increased in leptin treated
ob/ob mice, the conversion of T4 to T3 remains low. It

should be noted that Fehn et al. (1999) reported increased

thyroid gland activity in leptin treated ob/ob mice and did
not measure serum thyroid hormone levels.

The unexpected

hyperthyroid state observed in vehicle treated ob/ob mice
may be a mechanism to maintain a normal metabblism to
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cbmpensate for lack of leptiti.

The data show that ibpanoic

acid was effective at lowering serum T3 in ob/ob mice
relative to vehicle treated oh/ob mice.

lopanoic acid was administered to inhibit the

conversion of T4 to T3, through blocking the functipb of ^4
5'- monodeiodinase and a reduction in the T3/T4 ratio with

respect to vehicle was expected.

Ratios of T3/T4 display no

statistical difference among either +/? or ob/ob treatment
groups.

However, the negative feedback action of T4 on

pituitary thyrotropin production might have lowered T4 and

produced a normalization of the T3/T4 ratio that would have
otherwise decreased due to the decline in T3 (Hadley, 1982).

Normal (+/?) vehicle treated mice represent those
whose appetite and metabolic expenditure are uninfluenced

by exogenous hormonal manipulation.

Halaas et al. (1995)

reported that leptin treatment (12.5 /xg/g body weight) of
normal mice resulted in decreased food intake.

They

attributed the reduced food intake to a decreased metabolic

demand resulting from a leptin induced reduction of body

weight.

In the current study, leptin treatement (3 /xg/g

body weight) of +/? mice did not caUse a reduction of body

weight relative to vehicle treated +/? mice and thus their
exists no alteration in metabolic demand, as suggested by
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Halaas et al. (1995), and therfore a change in food

consTimption did not occur relative to vehicle treated
controls.

Daily food consumption for iopanoic acid and

iopanoic acid + leptin treated +/? mice were also unchanged
compared to vehicle treated controls,

Leptin's role as a satiety factor is shown in vehicle
treated ob/ob mice whose inability to produce functional

leptin results in greater food consumption with respect to
normal mice (figure 1).

The administration of leptin

inhibits feeding as seen by the observed depression of

daily food consumption relative to vehicle treated ob/ob
mice.

Iopanoic acid treated ob/ob mice had lower levels of

serum T3 relative to vehicle treated ob/ob mice (table 2).
The inability of these mice to produce functional leptin as

well as an inability to increase synthesis of T3 most likely
accounts for the depressed metabolic rate (figure 5).
Since the metabolic rates decreased in iopanoic acid
treated ob/ob mice while food consumption remained

unchanged, it was expected that the iopanoic acid treated
ob/ob mice would display a body weight above that of
vehicle treated ob/ob mice.

This did not occur and could

possibly be due to the chronic diarrhea observed in
iopanoic acid treated animals which continued for
34

approximately 6-7 days from the beginning of treatment.
The comibined treatmeht of leptin and iopanoio acid

depressed food consumption below that observed in either

leptin or iopanbic acid treated

V

Day 10 body weights; for normal i-k/?) mice were

uhaffected by any treatment Cfigure 2).

\

+/? treatment

groups consume similar ainouhts of food (figure 1), thus
supporting no observed change in body weights.

The percent

change in body weight with respect to day 1 was calculated
from actual body weights and reported in figure 3 (a,b).

lopanoic acid + leptin treated +/? mice showed a lower
percent change in body weight relative to all other +/?
treatment groups.

Obese (ob/ob) mice lack the ability to

synthesize functional leptin and this accounts for the
inability to effectively suppress appetite, which
contributes to the increase in body weight obseirved over
the course of the study.

Both leptin and T3 have been

described as inducers of metabolic expenditure (Lombardi et

al., 1997; Mistry et al., 1997), but since ob/ob mice lack

leptin, the high T3 levels observed in vehicle treated ob/ob
mice relative to vehicle treated +/? mice is possibly a
physiological compensation for lack of leptin and thus
accounts for the similar total oxygen consumption in this

group relative to Vehicle treated +/? mice (figure 5).
Leptin treatment in ob/ob mice causes a significant
reduction in body weight compared to vehicle treated ob/ob
mice.

This leptin effect is most likely the result of

appetite suppression/ which is consistent with the obseirved
reduction in food consiimption (figure 1), and increased

lipolytic activity (Shimabukuro et al 1997).

The inability

of leptin to elevate radiant body heat and oxygen

consumption in leptin treated ob/ob mice lends support to
the idea that the body weight reduction was not the result
of induced metabolic expenditure.

lopanoic acid treated

ob/ob mice lack leptin and display reduced serum T3 relative

to vehicle treated ob/ob mice (table 2).

treated ob/ob show a high

lopanoic acid

body weight relative to leptin

and iopanoic acid + leptin ob/ob mice due to the combined
absence of leptin as a Satiety factor and the reduced
metabolic rate associated with no leptin and the inability

to compensate through increasing thyroid hormone (T3).
Forty hours of fasting has been shown to reduce serum T4 and
T3 in rats by 28% and 38%, respectively (Kmiec et al.,

1998).

Interestingly, after a 48 hour fast, both leptin

binding to the arcuate nucleus (ARC) and the density of

leptin receptors on the ARC has also been shown to increase

■

by two-fold (Baskin et al., 1999).

In the current study

iopanoic acid reduced serxim T3 by 50% relative to vehicle

treated mice.

One might speculate that the expression of

leptin receptors on the arcuate nucleus are upregulated by
low levels of T3, and thus increases leptin sensitivity.

This wpuid support both a gresater inhibition of feeding
leading to a larger decrease in body weight in the iopanoic
acid + leptin treated ob/ob mice relative to ob/ob mice
treated with iopanoic acid alone.

Oxygen consumption and carbon dioxide production were
used to calculate the respiratory quotient (RQ) to provide
an indication of the metabolic substrate.

An RQ value of

0.71 indicates that fats are being used as the primary
source of fuel.

Normal +/? vehicle treatment group

displayed a day 10 RQ value below 0.71 (0.62 +005).

An

RQ value below 0.71 is indicative of either metabolic

alkalosis associated with hyperventilation, or a large

oxygen uptake after exercise so as to replenish an oxygen
debt (Schmidt-Nielson, 1990).

It is unclear as to whether

an RQ value below 0.71 in vehicle treated +/? mice was due
to experimental error or the above mentioned variables.

All other +/? treatment groups had day 10 respiratory
quotients that suggested fats as a primary source of fuel
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(figure 6).

All day 10 obese (ob/ob) mice display RQ

values that also indicate the utilization of fats.

All RQ

data seems unreliable.

Intracerebroventricular and systemic injections of

leptin have both been shown to increase metabolic rate
(Pelleymounter et al., 1995; Mistry et al., 1997; Ghibaudi
et al., 1996).

Although the pathway by which leptin causes

metabolic induction has not been fully identified, research

has provided evidence that both sympathetic activation via
the central nervous system (Haynes et al., 1997) and T3

induction (Fehn et al., 1999) remain the two major

possibilities.

A reduction in serum T3 accompanied a

depressed oxygen consumption in iopanoic acid treated ob/ob
mice relative to vehicle treated ob/ob mice, suggesting
that T3 was a major determinant of metabolic rate in fed

ob/ob mice (figure 5).

Interestingly, by maintaining a

depressed T3 state, relative to vehicle ob/ob mice, and
reintroducing leptin in iopanoic acid + leptin treated

ob/ob mice, we observed a similar oxygen consumption
relative to vehicle treated ob/ob mice (figure 5).

This

suggests that the leptin induced metabolic recovery does

not require an upregulation of T3.

Thus, sympathetic

activation apparently plays a much greater role in leptin
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influenced metabolism than does T3.

Furthermore, while T3

levels remain depressed in both leptin and iopanoic acid +

leptin treated ob/ob mice relative to vehicle treated ob/ob
mice, mean radiant body heat is higher in both groups
relative to the same control group (it should be noted that

leptin elevated radiant body heat relative to vehicle
treated ob/ob mice was not significant).
Studies support the thermogenic role of leptin acting
through increased thermogenic activity and an upregulation
of uncoupling protein 3 (Gong et al., 1997; Ghibaudi et
al., 1996).

Furthermore, it has been clearly established

that leptin functions to increase metabolic rate through

the upregulation of uncoupling proteins and oxygen

consumption in the ob/ob mouse (Cinti et al., 1997; Mistry
et al., 1997).

However, it has not been shown whether

leptin is able to act on peripheral tissue upregulation of
thermogenic activity or corresponding metabolic rate in the
absence of T3 induction.

Leptin induced heat production and

oxygen consumption in iopanoic acid + leptin ob/ob mice
relative to iopanoic acid ob/ob mice may be partially
attributed to an upregulated proton leak via skeletal
muscle uncoupling.
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The heat produced by the body is used to maintain a
relatively constant body temperature.

Thus any excess heat

that is produced as a result of either extrinsic factors,
such as leptin or thyroid hormone administration, or
intrinsic stimulation is emitted from the body surface.

Infrared emission was used as ah indicator of radiant body

heat with the arg\iment that heat emitted from siobcutaneous
vascularization is uninhibited by alterations in fat
insulation.

Therefore, radiant body heat was used as an

accurate indicator of heat production in excess to that
which is used in maintaining a core body temperature.

A

lower radiant body heat for vehicle treated ob/ob mice,
relative to +/? mice is interpreted as a reduced ability to

produce excessive heat to that which is used to maintain
constant body temperature and thus results in a lower
infrared emission.

Interestingly, the high T3 levels

associated with vehicle treated ob/ob mice indicates that
the low radiant body heat observed in this group, relative
to vehicle treated +/? mice, is not due to the T3 state.

Leptin's role as an inducer of metabolic expenditure
suggests that an increased radiant body heat should be

observed for leptin treated ob/ob mice relative to vehicle
treated ob/ob mice.

•Vv •: ■

However, radiant body heat in leptin
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treated db/pb mice was not elevated with respect tp vehicle
treated ob/ob mice.

In comparison, Pelleymounter et al.

(1995) observed an significant increase in core body-

temperature, however they administered leptin to ob/ob mice
at over 3 times concentration used in this study and for
over 3 times as long.

The lack of a detectable thermogenic

response in the current study is likely due to the lower
dose of leptin used and because the infrared emission

method measures excess radiant heat rather than core body
temperature.

Leptin treatment alone (3 |.ig/g) did not change oxygen

consumption in ob/ob mice relative to vehicle treated ob/ob
mice.

However, Pelleymounter et al.(1995) observed a

leptin induced oxygen consumption in ob/ob mice at

10 |ig/g but not at 0.1 fj,g/g or 1.0 |a.g/g. Interestingly,
while iopanoic acid treatment reduced oxygen consumption in
ob/ob mice relative to vehicle treated ob/ob mice,
simultaneous administration of leptin preserved oxygen

consumption rates equivilant to vehicle treated ob/ob
levels.

While oxygen consumption in iopanoic acid + leptin

ob/ob mice was restored to control (vehicle ob/ob mice)
levels, serum thyroid (T?) levels were not restored to
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control levels (vehicle ob/ob mice).

Furthermore, leptin

and ippanoic acid + leptin ob/ob mice display elevated
radiant body heat relative to both iopanoic acid and

vehicle treated ob/ob mice.

These data suggest that leptin

is able to induce thermogenesis and oxygen consumption
without upregulating the synthesis of T3.

Both leptin induced thermogenesis and oxygen
consumption rates provide evidence suggestive of metabolic

uncoupling, but they do not conclusively demonstrate this
phenomena.

Stronger evidence of uncoupling protein

incorporation into the mitochondrial membrane would include

the maintenance of metabolic rate accompanied by a rise in
thermogenesis.

However since leptin induces enzymes

associated with increased metabolism, such as acyl CoA
oxidase and carnitine palmitoyl transferase, an increas in
metabolism will always accompany a rise in thermogenesis
(Wang et al,, 1999; Zhou et al., 1997; Zhou et al., 1999).
There exists much evidence of leptin's ability to induce
metabolic uncoupling.

However, with advances in our

understanding of leptin's signalling pathways, it is
becoming apparent that there exists alternative pathways

through which leptin is able to stimulate peripheral tissue
metabolic uncoupling.

For instance, Mistry et al. (1997)
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and Wang et al. (1999) provide support of leptin's ability
to stimulate thermogenesis via induction of adrenal

synthesis of catecholamines.

A rise in catecholamine

levels induces lipolytic enzymes and increases fatty acid

levels, which in turn induce vmcoupling protein synthesis
(Weigle et al., 1998).

The current study was designed to

evaluate a proposed mechanism by which leptin acts on

peripheral tissue metabolic expenditure and thermogenesis
through the upregulation of thyroid hormone (T3).

The

results of the study show that while T3 levels are

suppressed in iopanoic acid treated ob/ob mice, leptin is
still able to induce both metabolic expenditure and

thermogenesis.

Further studies should be done to elucidate

whether the observed increase in radiant body heat is the

result of tissue specific upregulation of uncoupling
protein.
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Table 2.

Serum thyroid hormone concentrations (T3 and T4)

and the ratio of T3/T4 for day 10 normal (+/?) and obese
{ob/ob) mice. Vehicle treated obese mice displayed
significantly elevated T3 concentrations with respect to all
normal and obese treatment groups. Normal leptin treatment
group displayed a reduced serum T4 concentration with
respect to iopanoic acid + leptin treated obese mice. No

significant differences were observed in the T3/T4 for any
treatment groups. An outlier occurred for a single animal
in the T3/T4 for vehicle treatment (after the division
calculation), thus it was removed and a missing data point
was generated (n=4 was used to calculate ANOVA). Missing
data points occurred in vehicle normal T3 (n=4 was used to
calculate ANOVA), and iopanoic acid obese T3 (n=4 was used
to calculate ANOVA).

Normal(+/?)

Vehicle
Leptin
Iopanoic Acid
Iopanoic Acid + Leptin

Obese(ob/ob) Vehicle
Leptin
Iopanoic Acid
Iopanoic Acid + Leptin

T3/T4(ng/pg)

T3(ng/dl)

T4(Mg/dl)

96.9 + 21.0

4.0 + 0.8

23.1+6.5

64.1 +33.6

2.4 + 0.5

28.3 + 15.4

91.8 + 40.3

3.8 + 0.8

24.9 + 9.7

102.6 + 9.6

3.2 + 0.4

32.6 + 6.52

197.1 +44.3

3.5 + 1.7

41.6 + 6.7

116.8 + 23.3

3.3 + 0.5

35.3 + 6.7

100.7 + 21.2

4.1 + 1.3

120.7 + 38.0

4.4 + 1.2

26.2 + 4.9
30.3 + 17.6 

T3

+/V

+/L

+/I0P

+/IOP-L

ob/L

ob/lOP

ob/IOP-L

ob/V

s

S

s

S

s

s

s

T4

+/V

+/L

+/I0P

+/I0P-L

Ob/L

ob/lOP

ob/IOP-L

ob/lOP-L

NS

S

NS

NS

NS

NS

Symbols are defined as follows:

+/V = vehicle treated +/?;

+/L = Leptin treated +/?; +/IOP = Iopanoic acid treated
+/?; +/IOP-L = Iopanoic acid plus leptin treated +/?.
Obese (ob/ob) mice received same treatments but are

represented with the symbol ob/

.

Statistical

significance is shown in chart below table where treatment

groups intersect (S = significance; NS = not significant).
T3 and T4 statistical significant charts are separate, while
no T3/T4 chart is shown due to there being no significant
difference between treatment groups. All values are mean +
SD.
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Mean daily food consumption for each treatment

group of normal {+/?) and obese (oJb/oJb) mice (grams/day
total for each cage). Mean food consumption was analyzed
on the last 3 days (days 8-10). Obese (oh/oh) mice display
increased food consumption as compared to vehicle treated
normal (+/?) mice. Leptin treatment in ob/ob mice caused a
decrease in food consumption relative to +/? vehicle
treated mice. lopanoic acid + leptin treated ob/ob mice
displayed a decreased food consumption relative to both
vehicle treated +/? and iopanoic acid treated ob/ob mice.

Symbols are defined as follows: +/V= vehicle treated +/?;
+/L= Leptin treated +/?; +/I0P= lopanoic acid treated +/?;
+/I0P-L= lopanoic acid plus leptin treated +/?.

Obese

(ob/ob) mice received the same treatments but are

represented with the symbol ob/ . Statistical
significance is shown in a chart below the figure where
treatment groups intersect (S = significance; NS = not
significant). Values are mean + SD, n=3.
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Figure 2. Day 10 body weight for each treatment group of
normal {+/?) and obese {ob/pb) mice. All normal +/?
treatment groups remained the same body weight. Vehicle

treated obese mice display body weight higher than vehicle
treated normal mice* Leptin treatment in obese mice caused
a reduction in body weights with respect to vehicle treated
obese mice. lopanoic acid treated obese mice had higher
body weights than both leptin and iopanoic acid + leptin
treated obese treatment groups. lopanoic acid + leptin

treated obese mice displayed lower body weights than both
leptin and iopanoic acid treatment groups. Symbols are

defined as follows: +/V= vehicle treated +/?; +/L= Leptin
treated +/?; +/I0P= iopanoic acid treated +/?; +/lOP-L==

lopanoic acid plus leptin treated +/?.

Obese (ob/ob) mice

received the same treatments but are represented with the

symbol Ob/ . Statistical significance is shown in a chart
below the figure where treatment groups intersect
(S = significance; NS = not significant). Values are mean
+ SD, n=5.
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Figure 3 (a,b) . Percent change in body weight with
to day 1 for normal (a) and obese (b) mice. Mice were
treated with either vehicle (V) , leptin (L) , iopanoic acid
(lOP) , or iopanoic acid + leptin (lOP-L, lines which
correspond to each treatment are displayed in the figures) .
ANOVA was used to analyze percent change with respect to
day 1 of body weights for the final day. In order to
statistically evaluate all values of percent change as
positive numbers, a constant of 0.25 was added to the
percent change of each animal and then arcsin
transformation was applied to each the values (Zar,1984) .
Values are mean + standard deviation, n=5.
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Figure 4. Day 10 radiant body heat (°C) for each treatment
group of normal (+/?) and obese (ob/ob) mice. Normal
animals were unchanged by any treatment.

Vehicle treated

obese mice display a lower radiant body heat than vehicle
treated normal mice. lopanoic acid treated obese mice show
a radiant body heat lower than both leptin and iopanoic
acid + leptin treated obese mice. lopanoic acid + leptin
treated obese mice have a higher radiant body heat than
both vehicle and iopanoic acid treated obese mice. Symbols

are defined as follows:

+/V= vehicle treated +/?; +/L=

Leptin treated +/?; +/IOP= lopanoic acid treated +/?;
+/lOP-L= lopanoic acid plus leptin treated +/?. Obese
(ob/ob) mice received the same treatments but are

represented with the symbol ob/ . Statistical
significance is shown in a chart below the figure where
treatment groups intersect

(S = significance; NS = not significant).
+ SD, n=5.
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Day 10 oxygen consumption rate (ml O2 . min ")

for day 10 normal (+/?) and obese {ob/ob) mice.

lopanoic

acid treated obese mice display a reduced oxygen
consumption rates relative to the noted treatment groups in

the chart. Symbols are defined as follows: +/V (day)="
vehicle treated +/?; +/L = Leptin treated +/?; +/IOP =

lopanoic acid treated +/?; +/IOP-L = lopanoic acid plus
leptin treated +/?. Obese {ob/ob) mice received the same
treatments but are represented with the symbol ob/ .
Statistical significance is shown in a chart below the
figure where treatment groups intersect (S = significance;
NS = not significant).

Values are mean + SD, n=5.
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Respiratory quotients (RQ) for day 10 normal

(+/?) and obese {ob/ob) treatment groups.

Day 10 vehicle

and leptin treated obese mice display an RQ value above
vehicle treated normal mice. Symbols are defined as

follows: +/V (day)= vehicle treated +/?; +/L = Leptin
treated +/?; +/IOP = lopanoic acid treated +/?; +/IOP-L =

lopanoic acid plus leptin treated +/?.

Obese {ob/ob) mice

received the same treatments but are represented with the

symbol ob/

.

Statistical significance is shown in a

chart below the table where treatment groups intersect (S =
significance; NS = not significant). Values are mean + SD,
n=5.
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Appendix C. Radiant body heat (°C) for day 1 and day 10
normal (+/?) and obese (ob/ob) mice. Radiant body heat is
not different between any groups on day 1. There are no
significant temperature changes between day 1 and day 10
for any normal treated group-

All obese treated groups

display decreased radiant body heat from day 1 to day 10.
Day 10 iopanoic acid + leptin treated obese mice are
significantly higher than day 10 vehicle and day 10
iopanoic acid treated obese mice. Symbols are defined as

follows: +/V (day)= vehicle treated +/?; +/L (day)= Leptin
treated +/?; +/IOP (day)= Iopanoic acid treated +/?; +/IOP
L (day)= Iopanoic acid plus leptin treated +/?. Obese
{ob/ob) mice received the same treatments but are

represented with the symbol ob/___ (day).

Statistical

significance is shown in a chart below figure where

treatment groups intersect (S = significance; NS = not
significant). Statistical analysis was performed using
Repeated Measure Analysis of Variance. Values are mean +
SP, n=5.
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S
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Oxygen consumption rates (ml O2 . min'^)

days 1 and 10 for normal {+/?) and obese mice.

All normal

and obese mice had eqiiivalant day 1 oxygen cohsiomption rate
values. lopanoic acid treated obese mice display a reduced
day 10 oxygen consumption relative to day 1 and all other
day 10 obese treatment groups. Symbols are defined as

follows: +/V (day)= vehicle treated +/?; +/L (day)= Leptin
treated +/?; +/IOP (day)= lopanoic acid treated +/?; +/IOP
L (day)= lopanoic acid plus leptin treated +/?. Obese
(ob/oh) mice received the same treatments but are

represented with the symbol ob/

(day).

Statistical

significance is shown in a chart below the table where
treatment groups intersect (S = significance; NS = not
significant). Statistical analysis was performed using
Repeated Measure Analysis of Variance. Values are mean _+
SD, n=5.
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Appendix E.

Respiratory quotient (RQ) for day 1 and day 10

comparison of normal (+/?) and obese (ob/ob) treatment
groups. All day 1 treatment groups, except for the
iopanoic acid + leptin obes mice, have RQ values that
suggest fat metabolism. All day 10 treatment groups have
RQ values that indicate fat metabolism. Symbols are

defined as follows: +/V (day)= vehicle treated +/?; +/L
(day)= Leptin treated +/?; +/IOP (day)= Iopanoic acid
treated +/?; +/IOP-L (day)= Iopanoic acid plus leptin
treated +/?.

Obese (ob/ob) mice received same treatments

but are represented with the symbol ob/_

(day).

Statistical significance is shown in^ chart below table
where treatment groups intersect (S = significance; NS =
not significant). Statistical analysis was performed using
Repeated Measure Analysis of Variance. Values are mean +
SD, n=5.
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